Morphological changes in mcf-7 human breast cancer cells in response to bis-naphthalimidopropylspermidine-treatment

Biotechnology and Biotechnological Equipment

Volumn 16, Issue 1, 2002, Pages 118-123

  Pavlov, V ^a   Rodilla, V ^b   Lin, P Kong Thoo ^c  

^a UNIVERSITY OF SOFIA   (Bulgaria)

^b Facultad de Ciencias Experimentales y de la Salud   (Spain)

^c ROBERT GORDON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISNAPHTHALIMIDOPROPYLSPERMIDINE; HOE 33342; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL NUCLEUS; CELL SHAPE; CELL STRAIN MCF 7; CELL STRUCTURE; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DRUG EFFECT; GIEMSA STAIN; HUMAN; HUMAN CELL;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0036979303     PISSN: 13102818     EISSN: None     Source Type: Journal    
DOI: 10.1080/13102818.2002.10819165     Document Type: Article

References (22)

1. Tabor C.V., Tabor H., (1984) Polyamines. Annu. Rev. Biochem., 53, 749–790.
2. Thomas T., Thomas T.J., (2001) Mol. Life Sci., 58, 244–258.
3. Casero R.A., Woster P.M., (2001) J. Med. Chem., 4, 1–26.
4. Seiler N., Delcros J., Vaultier M., Le Roch N., Havouis R., Douaund F., et al. (1996) Cancer Res., 56, 5624–5630.
5. Eiseman J.L., Rogers F.A., Guo Y., Kauffman J., Sentz D.L., Klinger M.F., Callery P.S., Kyprianou N., (1998) Cancer Res., 58, 4864–4870.
6. Kuksa V.A., Pavlov V.A., Kong Thoo Lin P., (2000) Bioorg. Med. Chem. Lett., 10, 1265–1267.
7. Kuksa V.A., Pavlov V.A., Kong Thoo Lin P., (2002) Bioorg. Med. Chem., 10, 691–697.
8. McCloskey D.E., Casero R.A., Woster P.M., Davidson N.E., (1995) Cancer Res., 55, 3233–3236.
9. Ha C.H., Woster P.M., Yager, J.D., Casero R.A., (1997) Proc. Natl. Acad. Sci. USA, 94, 11557–11562.
10. Kroemer G., Petit P., Zamzami N., Vayssiere J.L., Mignotte B., (1995) FASEB J., 9, 1277–1287.
11. Leist M., Nicotera P., (1997) Biochem. Biophys. Res. Commun, 236, 1–9.
12. Kong Thoo Lin P., Pavlov V.A., (2000) Bioorg. Med. Chem. Lett., 10, 1609–1611.
13. Pavlov V., Kong Thoo Lin P., Rodilla V., (2001) Chem. Biol. Interact., 137, 15–23.
14. Mossman T., (1983) J. Immunol. Methods. 65, 55–63.
15. Kerr J.F.R., Winterford C.M., Harmon B.V., (1994) Apoptosis:its significance in cancer and cancer therapy. Cancer, 73, 2013–2026.
16. Davidson N.E., Mank A.R., Prestigiacomo L.J., Bergeron R.J., Casero R.A., (1993) Cancer Research, 53, 2071–2075.
17. Hadjiolov A.A., (1985) The nucleolus and ribosome biogenesis, Springer Verlag.
18. Olson M.O., J, Dundr M., Szebeni A., (2000) Trends Cell Biol., 10, 189–196.
19. Miller M.L., Andringa A., Dixon K., Carty M., (2002) Micron, 33, 157–166.
20. Cmarko D., Verschure P.J., Rothblum L.I., HernandezVerdun D., Amalric F., van Driel R., Fakan S., (2000). Histochem. Cell Biol., 113, 181–187.
21. Fearnhead H.O., Dinsdale D., Cohen G.M., (1995) FEBS Let., 375, 283–288.
22. Horky M., Wurzer G., Kotala V., Anton M., Vojtesec B., Vacha J., Weslerska-Gadek J., (2001) J. Cell Sci, 114, 663–670.